SCHEMBL4201006

SCHEMBL4201006

CCC[C@@H](C)CC(O)CC(=O)OCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.37
ALDH1A1 P00352 3/20 0.36
TRPA1 O75762 1/20 0.36
CYP1A2 P05177 1/20 0.36
MAPT P10636 1/20 0.35
KMT2A Q03164 3/20 0.35
TSHR P16473 2/20 0.35
CYP3A4 P08684 2/20 0.35
ALOX15 P16050 2/20 0.35
POLB P06746 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CHRM1 P11229 1/20 0.34
ADORA1 P30542 1/20 0.34
HSD17B10 Q99714 1/20 0.34
KDM4E B2RXH2 1/20 0.33
DUSP3 P51452 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4199062 1.00 MGAM (0.39) MGAMGAASIMGAM2L3MBTL1
SCHEMBL4200909 0.90 MAPT (0.40) MGAMGAASIMGAM2CYP1A2
SCHEMBL4205690 0.90 MAPT (0.40) MGAMGAASIMGAM2CYP1A2
SCHEMBL5164571 0.90 MAPT (0.40) MGAMGAASIMGAM2CYP1A2
SCHEMBL4203015 0.85 MGAM (0.41) MGAMGAASIMGAM2L3MBTL1
SCHEMBL4207955 0.85 MGAM (0.41) MGAMGAASIMGAM2L3MBTL1
SCHEMBL5001444 0.83 MGAM (0.46) MGAMGAASIMGAM2L3MBTL1
SCHEMBL7952798 0.83 MGAM (0.46) MGAMGAASIMGAM2L3MBTL1
SCHEMBL5477958 0.83 MGAM (0.46) MGAMGAASIMGAM2L3MBTL1
SCHEMBL5483236 0.83 MGAM (0.46) MGAMGAASIMGAM2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247743-A1 PREPARATION OF BETA-AMINO ACIDS HAVING AFFINITY FOR THE ALPHA-2-DELTA PROTEIN PFIZER INC 2009-10-01 US claimed
EP-1768952-A2 PREPARATION OF BETA-AMINO ACIDS HAVING AFFINITY FOR THE ALPHA-2-DELTA PROTEIN Warner-Lambert Company LLC (US) 2007-04-04 EP claimed
WO-2006008612-A2 PREPARATION OF BETA-AMINO ACIDS HAVING AFFINITY FOR THE ALPHA-2-DELTA PROTEIN WARNER-LAMBERT COMPANY LLC (US) 2006-01-26 WO claimed
US-20090247743-A1 PREPARATION OF BETA-AMINO ACIDS HAVING AFFINITY FOR THE ALPHA-2-DELTA PROTEIN PFIZER INC 2009-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247743-A1 PREPARATION OF BETA-AMINO ACIDS HAVING AFFINITY FOR THE ALPHA-2-DELTA PROTEIN SCN2A, SCN1A, ORAI2 MGAM 4471/4885GAA 3224/4885SI 3484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.